Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland 21225


Purpose:

To test the ability of GSK256073 to block niacin-induced flushing when GSK256073 and niacin are co-administered as single doses to HVTs.


Criteria:

Inclusion Criteria: - Adult males between 18 and 55 years of age, inclusive. - Healthy subjects - Body weight > 50 kg (110 pounds) and body mass index (BMI) between 19 and 31 where: - Subjects with QTc < 450 msec at screening Exclusion Criteria: - History of significant cardiac arrhythmias - Active peptic ulcer disease (PUD) and/or history of PUD - History of gout and/or hyperuricemia - History of Gilbert's syndrome - History of recurrent indigestion, stomach upset or diarrhea - History of other than rare (once yearly or less) flushing - Recurrent skin rash or psoriasis - History of kidney stones


NCT ID:

NCT00608699


Primary Contact:

Study Director
GSK Clinical Trials
GlaxoSmithKline


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland 21225
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.